In the pharmaceutical business, there are two separate challenges. One is research and development of new drugs and the other ensuring breakthroughs are made before the competition.
Business intelligence (BI) solutions are becoming more and more popular in several industries as companies continuously explore strategies to get ahead of the competition. In the pharmaceutical business, there are two separate challenges. One is research and development of new drugs and the other ensuring breakthroughs are made before the competition.
Read more about such challenges here.
Data from ResearchandMarkets suggest that
global healthcare BI market accounted for US$3.8 billion in 2017 and is expected to reach $15.9 billion by 2026 growing at a CAGR of 17.4 percent. ...